Back
Relay Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
RLAY
Relay Therapeutics, Inc.
Last Price:
$8.33
Seasonality Move:
-13.11%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLAY is experiencing slight buying pressure.
Relay Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.24 | Buy |
| 20-day SMA: | 7.97 | Buy |
| 50-day SMA: | 7.18 | Buy |
| 200-day SMA: | 4.43 | Buy |
| 8-day EMA: | 5.3 | Buy |
| 20-day EMA: | 2.74 | Buy |
| 50-day EMA: | 1.23 | Buy |
| 200-day EMA: | 0.33 | Buy |
Relay Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 65.82 | Buy |
| Chaikin Money Flow: | 880737 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.02 - 8.34) | Buy |
| Bollinger Bands (100): | (4.01 - 7.39) | Buy |
Relay Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relay Therapeutics, Inc. Stock
Is Relay Therapeutics, Inc. Stock a Buy?
-
Relay Therapeutics, Inc. share price is 8.61 while RLAY 8-day simple moving average is 8.24, which is a Buy signal.
-
The stock price of RLAY is 8.61 while Relay Therapeutics, Inc. 20-day SMA is 7.97, which makes it a Buy.
-
Relay Therapeutics, Inc. 50-day simple moving average is 7.18 while RLAY share price is 8.61, making it a Buy technically.
-
RLAY stock price is 8.61 and Relay Therapeutics, Inc. 200-day simple moving average is 4.43, creating a Buy signal.
RLAY Technical Analysis vs Fundamental Analysis
Buy
68
Relay Therapeutics, Inc. (RLAY)
is a Buy
Is Relay Therapeutics, Inc. a Buy or a Sell?
-
Relay Therapeutics, Inc. stock is rated a BuyThe current Relay Therapeutics, Inc. [RLAY] share price is $8.61. The Score for RLAY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Relay Therapeutics, Inc. Stock Info
Market Cap:
1.5B
Price in USD:
8.61
Share Volume:
5.3M
Relay Therapeutics, Inc. 52-Week Range
52-Week High:
9.04
52-Week Low:
1.78
Buy
68
Relay Therapeutics, Inc. (RLAY)
is a Buy
Relay Therapeutics, Inc. Share Price Forecast
-
What is the Relay Therapeutics, Inc. stock price today?The Relay Therapeutics, Inc. stock price is 8.61 USD today.
-
Will RLAY stock go up or go down?Relay Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Relay Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics, Inc. is not overvalued.
Is Relay Therapeutics, Inc. Stock a Buy?
-
Relay Therapeutics, Inc. share price is 8.61 while RLAY 8-day exponential moving average is 5.30, which is a Buy signal.
-
The stock price of RLAY is 8.61 while Relay Therapeutics, Inc. 20-day EMA is 2.74, which makes it a Buy.
-
Relay Therapeutics, Inc. 50-day exponential moving average is 1.23 while RLAY share price is 8.61, making it a Buy technically.
-
RLAY stock price is 8.61 and Relay Therapeutics, Inc. 200-day simple moving average is 0.33, creating a Buy signal.
Fundamental Analysis of Relay Therapeutics, Inc.
Is Relay Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.14 per share.
Technical Analysis of Relay Therapeutics, Inc.
Should I short Relay Therapeutics, Inc. stock?
-
RLAY Moving Average Covergence Divergence (MACD) indicator is 1.86, suggesting Relay Therapeutics, Inc. is a Buy
-
Relay Therapeutics, Inc. Relative Strength Index (RSI) is 65.82, which suggest Relay Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Relay Therapeutics, Inc. is (7.02 - 8.34), which suggest Relay Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Relay Therapeutics, Inc. is (4.01 - 7.39), which suggest Relay Therapeutics, Inc. is a Buy
* Relay Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.